Local Institution - 032 — New York, New York

Local Institution - 032 is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Local Institution - 032 has participated in 1 clinical trials.

Therapeutic areas: Pancreatic Neoplasms, Digestive System Neoplasms, Neoplasms by Site.

Sponsors: Celgene.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 032?

Local Institution - 032 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 032 conducted?

Local Institution - 032 has 1 clinical trials on record. Their work covers Pancreatic Neoplasms, Digestive System Neoplasms, Neoplasms by Site.

Is Local Institution - 032 accredited by Crixeo Health?

Local Institution - 032 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Local Institution - 032?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.